CareDx, Inc
CDNA
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cā¦ read more
Healthcare
Diagnostics & Research
9 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$13.91
Price+6.15%
$0.81
1Y
Price
Market Cap
$740.120m
Small
Price/Earnings 3y Avg5y Avg
12.9x
Premium
Premium
Financials Overview
Key metrics over the past few years-
EBITDA Margin-
Net Profit Margin-
Free Cash Flow MarginRevenue
$340.826m
-
1y CAGR-
3y CAGR-
5y CAGREarnings
$51.681m
-
1y CAGR-
3y CAGR-
5y CAGREPS
$1.02
-
1y CAGR-
3y CAGR-
5y CAGRBook Value
$327.370m
$444.257m
Assets$116.887m
Liabilities$29.122m
DebtDebt to Assets
6.6%
-1x
Debt to EBITDAFree Cash Flow
$17.847m
-
1y CAGR-
3y CAGR-
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company